This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Da Hyeon Park: Innovator in Immune-Stimulating Therapies
Introduction
Da Hyeon Park is a notable inventor based in Hwaseong-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of immunology through his innovative research and development efforts. His work focuses on creating novel therapeutic solutions that enhance immune responses.
Latest Patents
Da Hyeon Park holds a patent for a "Novel Conjugate of Immune-Stimulating IL-2 Analog and Preparation Method Thereof." This patent represents a significant advancement in the development of immune-stimulating therapies, showcasing his expertise and commitment to improving health outcomes.
Career Highlights
Currently, Da Hyeon Park is employed at Hanmi Pharmaceutical Co., Ltd., where he continues to push the boundaries of medical research. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative healthcare solutions.
Collaborations
Da Hyeon Park has worked alongside esteemed colleagues such as Yong Ho Heo and Euh Lim Oh. These collaborations have fostered a dynamic environment for innovation and have led to the development of groundbreaking therapeutic approaches.
Conclusion
Da Hyeon Park exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to advancing immune therapies through his patent and collaborative efforts highlights the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile